ABCB1 and neoplasm: Cbz is a second-generation taxane, and compared to docetaxel and paclitaxel, it has low affinity for P-glycoprotein efflux pumps, making it suitable for tumours that exhibit resistance by increased expression of P-glycoprotein [30].